Novavax, Inc. (NVAX)

Last Closing Price: 7.96 (2026-11-18)

Long-Term Liabilities (Quarterly)

Long-Term Liabilities: The sum of all non-current liabilities.

Novavax, Inc. (NVAX) had Long-Term Liabilities of $775.01M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$68.30M
$-31.38M
$23.49M
$44.81M
$99.58M
$-31.28M
$1.63M
$-29.65M
$-29.65M
$-31.38M
$-31.38M
$-31.38M
$-31.38M
$-31.28M
$-28.23M
164.92M
164.92M
$-0.19
$-0.19
Balance Sheet Financials
$707.96M
$36.28M
$180.05M
$888.00M
$329.85M
$293.61M
Long-Term Liabilities
$775.01M
$1.10B
$-216.85M
$-328.93M
$-216.85M
164.99M
Cash Flow Statement Financials
$-199.47M
$134.32M
$36.88M
$256.05M
$227.06M
$-29.00M
$23.77M
--
--
Fundamental Metrics & Ratios
2.15
--
--
3.83
-1.36
65.61%
-45.80%
-45.80%
--
-43.42%
-45.94%
$-202.35M
--
--
--
0.08
1.27
1.39
64.78
14.47%
9.54%
-3.53%
-40.88%
$-1.31
$-1.23
$-1.21